Log in

NASDAQ:QTRXQuanterix Stock Price, Forecast & News

$27.13
-0.75 (-2.69 %)
(As of 07/7/2020 04:00 PM ET)
Add
Compare
Today's Range
$26.67
Now: $27.13
$27.93
50-Day Range
$24.05
MA: $26.44
$27.94
52-Week Range
$10.90
Now: $27.13
$33.67
Volume135,215 shs
Average Volume167,909 shs
Market Capitalization$768.08 million
P/E RatioN/A
Dividend YieldN/A
Beta1.77
Quanterix Corporation, a life sciences company, develops and markets ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Simoa HD-1 instrument, a sensitive automated multiplex protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection technology in various applications, including direct detection of nucleic acids. It also develops SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include kits, such as beads, capture and detector reagents, enzyme reagents, and enzyme substrates to run tests; and consumables, such as proprietary Simoa disks, cuvettes, and disposable tips. In addition, it offers contract research services, including sample testing, homebrew assay development, and custom development services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sell its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct sales force, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Lexington, Massachusetts.
Read More
Quanterix logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.5Community Rank: 2.2Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.27 out of 5 stars


Industry, Sector and Symbol

Industry Analytical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:QTRX
CUSIPN/A
Phone617-301-9400

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$56.73 million
Book Value$4.59 per share

Profitability

Net Income$-40,800,000.00

Miscellaneous

Employees177
Market Cap$768.08 million
Next Earnings Date8/4/2020 (Estimated)
OptionableNot Optionable

Receive QTRX News and Ratings via Email

Sign-up to receive the latest news and ratings for QTRX and its competitors with MarketBeat's FREE daily newsletter.

Quanterix (NASDAQ:QTRX) Frequently Asked Questions

How has Quanterix's stock been impacted by COVID-19 (Coronavirus)?

Quanterix's stock was trading at $18.51 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, QTRX shares have increased by 46.6% and is now trading at $27.13. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Quanterix?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Quanterix in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Quanterix.

When is Quanterix's next earnings date?

Quanterix is scheduled to release its next quarterly earnings announcement on Tuesday, August 4th 2020. View our earnings forecast for Quanterix.

How were Quanterix's earnings last quarter?

Quanterix Corp (NASDAQ:QTRX) issued its quarterly earnings data on Tuesday, May, 5th. The company reported ($0.39) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($0.36) by $0.03. The firm had revenue of $15.73 million for the quarter, compared to analysts' expectations of $12.70 million. Quanterix had a negative return on equity of 36.97% and a negative net margin of 70.51%. View Quanterix's earnings history.

What price target have analysts set for QTRX?

2 brokerages have issued 12 month price objectives for Quanterix's shares. Their forecasts range from $32.00 to $35.00. On average, they anticipate Quanterix's share price to reach $33.50 in the next year. This suggests a possible upside of 23.5% from the stock's current price. View analysts' price targets for Quanterix.

Has Quanterix been receiving favorable news coverage?

News coverage about QTRX stock has been trending negative this week, InfoTrie Sentiment reports. InfoTrie ranks the sentiment of news coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Quanterix earned a news sentiment score of -2.1 on InfoTrie's scale. They also gave media stories about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the next few days. View the latest news about Quanterix.

Are investors shorting Quanterix?

Quanterix saw a decline in short interest during the month of June. As of June 15th, there was short interest totaling 1,060,000 shares, a decline of 6.2% from the May 31st total of 1,130,000 shares. Based on an average trading volume of 186,500 shares, the days-to-cover ratio is currently 5.7 days. Currently, 5.5% of the company's stock are sold short. View Quanterix's Current Options Chain.

Who are some of Quanterix's key competitors?

What other stocks do shareholders of Quanterix own?

Who are Quanterix's key executives?

Quanterix's management team includes the following people:
  • Mr. E. Kevin Hrusovsky, Chairman, Pres & CEO (Age 58)
  • Dr. David R. Walt, Co-Founder, Chairman of Scientific Advisory Board & Director (Age 66)
  • Dr. David C. Duffy Ph.D., Sr. VP of R&D and CTO (Age 48)
  • Mr. Amol Chaubal, Chief Financial Officer (Age 43)
  • Mr. Bruce J. Bal, VP of Operations, Service & Quality (Age 60)

When did Quanterix IPO?

(QTRX) raised $50 million in an initial public offering on Thursday, December 7th 2017. The company issued 3,300,000 shares at $14.00-$16.00 per share. J.P. Morga and Leerink Partners acted as the underwriters for the IPO and BTIG and Evercore ISI were co-managers.

What is Quanterix's stock symbol?

Quanterix trades on the NASDAQ under the ticker symbol "QTRX."

How do I buy shares of Quanterix?

Shares of QTRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Quanterix's stock price today?

One share of QTRX stock can currently be purchased for approximately $27.13.

How big of a company is Quanterix?

Quanterix has a market capitalization of $768.08 million and generates $56.73 million in revenue each year. The company earns $-40,800,000.00 in net income (profit) each year or ($1.63) on an earnings per share basis. Quanterix employs 177 workers across the globe.

What is Quanterix's official website?

The official website for Quanterix is www.quanterix.com.

How can I contact Quanterix?

Quanterix's mailing address is 900 MIDDLESEX TURNPIKE, BILLERICA MA, 01821. The company can be reached via phone at 617-301-9400.

This page was last updated on 7/8/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.